Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.9, 2007-01, pp. : 793-800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of Stress Urinary Incontinence: A Claims Data Analysis

By Birnbaum H.G.

PharmacoEconomics, Vol. 22, Iss. 2, 2004-01 ,pp. : 95-105

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis

By Nuijten Mark J.C. Wittenberg Wolfgang Lebmeier Maximilian

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-71

Adis International

Access to resources Recommend Favorite

Palivizumab

By Scott L.J. Lamb H.M.

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Palivizumab pharmacy programme cost saving in the US

Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comparison of Corticosteroid Nasal Sprays in Relation to Concomitant Use and Cost of Other Prescription Medications to Treat Allergic Rhinitis Symptoms: Retrospective Cohort Analysis of Pharmacy Claims Data

By Garris Cindy

Clinical Drug Investigation, Vol. 29, Iss. 8, 2009-08 ,pp. : 515-526

Adis International

Access to resources Recommend Favorite